Pharmacodynamic studies with a new progestational substance -- ORG 2969 -- in combination with ethinyloestradiol.
D000328:Adult; D001831:Body Temperature / Q000187:drug effects; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004341:Drug Evaluation; D004717:Endometrium / Q000166:cytology / Q000187:drug effects*; D004958:Estradiol / Q000097:blood; D004963:Estrenes / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D004997:Ethinyl Estradiol / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006718:Homosteroids / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D006801:Humans; D008099:Liver / Q000187:drug effects; D008111:Liver Function Tests; D007986:Luteinizing Hormone / Q000097:blood; D010053:Ovary / Q000187:drug effects*; D010060:Ovulation / Q000187:drug effects*; D010903:Pituitary Gland, Anterior / Q000187:drug effects*; D011374:Progesterone / Q000097:blood; D045167:Progesterone Congeners / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D011388:Prolactin / Q000097:blood
D004338:Drug Combinations; D004963:Estrenes; D006718:Homosteroids; D045167:Progesterone Congeners; D004997:Ethinyl Estradiol; D011374:Progesterone; D004958:Estradiol; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone